Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients
NCT01322789
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus, Insulin-Dependent
Interventions
BIOLOGICAL:
Intravenous Mesenchymal stem cell infusion
Sponsor
University of Sao Paulo